Rhythm Pharmaceuticals
RYTM
RYTM
85 hedge funds and large institutions have $970M invested in Rhythm Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 38 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
4.32% more ownership
Funds ownership: 89.3% → 93.63% (+4.3%)
Holders
85
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$48.2M | |
| 2 | +$37.4M | |
| 3 | +$20.6M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$18.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.6M |
Top Sellers
| 1 | -$26.1M | |
| 2 | -$6.34M | |
| 3 | -$5.79M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.58M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$2.15M |